Brivudine

Brivudine is a nucleoside-analogue antiviral that, after viral thymidine-kinase-mediated phosphorylation, inhibits herpesviral DNA polymerase, used for the treatment of herpes zoster (shingles). Simson Pharma's Brivudine reference standard and impurities support compendial testing for this antiviral therapy.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Brivudine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Brivudine
Brivudine Impurity 1
Brivudine Impurity 2
Brivudine Impurity 4
alpha-(E)-Brivudine
Brivudine Impurity 8
Brivudine Impurity 3
Benzylpenicillin

Isotope Labelled Compounds

Brivudine-13C-15N2